NeuroX1 is a computational drug design company focused on neurodegenerative disorders, utilizing machine learning to identify novel drug targets and design small molecules
NeuroX1 is a computational drug design company focused on neurodegenerative disorders, utilizing machine learning to identify novel drug targets and design small molecules. They operate a cloud-based platform for high-performance computing in drug discovery.